TB-500
Thymosin Beta-4 fragment
Promotes cell migration and tissue regeneration.
Mechanism of Action
Actin-binding for cell migration, angiogenesis, and inflammation control.
Key Benefits
- Faster wound/injury healing
- Improved flexibility
Common Uses
What to Expect
Onset
Gradual over 1–2 weeks; flexibility improvements often noticed first
Duration
Effects build through 4–8 week cycle; systemic healing benefits persist after stopping
What Users Report
- Gradual but meaningful improvement in flexibility and range of motion — joints and muscles feel 'looser'
- Chronic aches and stiffness that have lingered for months start to resolve
- Injuries feel more mobile and less 'stuck'; scar tissue seems to soften
- Some users notice improved hair growth and thickness as a secondary effect
- General improvement in tissue quality — skin heals faster from cuts and scrapes
- Effects are more systemic and whole-body compared to BPC-157's targeted action
Typical Timeline
Week 1: Loading phase — subtle changes, possible mild fatigue. Weeks 2–3: Flexibility improvements become noticeable; chronic stiffness begins resolving. Weeks 4–6: Significant healing progress in injured areas. Weeks 6–8: Full benefits realized; many users report feeling physically 'younger' in their movements.
Side Effects
- Minimal
Dosage Protocol
Loading: 2–7.5 mg subcutaneously 2x/week for 2 weeks, then maintenance 2–5 mg/week. Cycles: 4–8 weeks. Site-specific injection optional. Research protocols only.
Always consult a physician before starting any peptide protocol.
Administration
Subcutaneous injection
FDA Status
Category 2 (potential reclassification 2026)
Stacks Well With
- BPC-157
Tags
Related peptides
BPC-157
Body Protection Compound-157
Synthetic gastric peptide famous for rapid tissue repair.
PEG-MGF
Pegylated Mechano Growth Factor
Long-acting mechano growth factor for localized muscle repair and hypertrophy.